Eurazeo, ADM in €60m round for M2I
Five investors, including Eurazeo Growth and ADM Capital, have invested €60m in a funding round for complex molecules producer M2I Life Sciences.
More on Expansion
DeA Capital's Idea CCR II backs Pieralisi
Deal follows the acquisition of the company's bank debt by Idea CCR II in December 2017
PE-backed Avisa bolts on consulting firm CEIS
Merger will help the group provide a wider range of cybersecurity-related services
BPI France, Pymwymic et al. back Naïo Technologies
Investors back the robot designer and manufacturer to help increase its production
Stripes leads $150m round for Snyk at $1bn+ valuation
Investors such as Coatue, Tiger Global, BoldStart and Salesforce Ventures also participated
Latest News
Partners Group buys VSB majority stake
Renewable energy service will also receive future growth funding from the GP
Pantheon joins forces with Kermony for France-focused push
Relationship is set to facilitate access to Pantheon's offering for French institutional investors
DeA Capital's Idea CCR II backs Pieralisi
Deal follows the acquisition of the company's bank debt by Idea CCR II in December 2017
Clearwater opens Leeds office, appoints Goldsack
Newly appointed partner Richard Goldsack previously worked at Grant Thornton and EY